Charles Zhou
Stock Analyst at Guggenheim
(2.96)
# 1,299
Out of 5,182 analysts
8
Total ratings
83.33%
Success rate
48.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences | Maintains: Buy | $17 → $20 | $35.87 | -44.24% | 2 | Aug 25, 2025 | |
| FUTU Futu Holdings | Maintains: Buy | $130 → $136 | $168.00 | -19.05% | 3 | Mar 17, 2025 | |
| ZYME Zymeworks | Reiterates: Buy | $16 | $27.61 | -42.05% | 1 | Mar 8, 2023 | |
| MGNX MacroGenics | Downgrades: Neutral | n/a | $3.01 | - | 1 | May 5, 2022 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $56 | $1.45 | +3,762.07% | 1 | Aug 2, 2021 |
Cogent Biosciences
Aug 25, 2025
Maintains: Buy
Price Target: $17 → $20
Current: $35.87
Upside: -44.24%
Futu Holdings
Mar 17, 2025
Maintains: Buy
Price Target: $130 → $136
Current: $168.00
Upside: -19.05%
Zymeworks
Mar 8, 2023
Reiterates: Buy
Price Target: $16
Current: $27.61
Upside: -42.05%
MacroGenics
May 5, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.01
Upside: -
PMV Pharmaceuticals
Aug 2, 2021
Initiates: Buy
Price Target: $56
Current: $1.45
Upside: +3,762.07%